Golden State Wealth Management, LLC Sage Therapeutics, Inc. Call Options Transaction History
Golden State Wealth Management, LLC
- $667 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SAGE
# of Institutions
191Shares Held
45.7MCall Options Held
385KPut Options Held
209K-
Black Rock Inc. New York, NY5.22MShares$37.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.84MShares$34.7 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$32 Million0.54% of portfolio
-
Rtw Investments, LP New York, NY3MShares$21.6 Million0.27% of portfolio
-
State Street Corp Boston, MA2.93MShares$21 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $427M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...